Prostatic Secretory Proteins
"Prostatic Secretory Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins secreted by the prostate gland. The major secretory proteins from the human prostate gland include PROSTATE-SPECIFIC ANTIGEN, prostate-specific acid phosphatase, prostate-specific membrane antigen, and prostate-specific protein-94.
Descriptor ID |
D029584
|
MeSH Number(s) |
D12.776.866.249
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Secretory Proteins".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Secretory Proteins".
This graph shows the total number of publications written about "Prostatic Secretory Proteins" by people in this website by year, and whether "Prostatic Secretory Proteins" was a major or minor topic of these publications.
Below are the most recent publications written about "Prostatic Secretory Proteins" by people in Profiles.
-
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort. BJU Int. 2021 08; 128(2):218-224.
-
Novel method to rescue a lethal phenotype through integration of target gene onto the X-chromosome. Sci Rep. 2016 11 15; 6:37200.
-
Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations. J Natl Cancer Inst. 2013 Feb 06; 105(3):237-43.
-
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Mol Cell Proteomics. 2012 Dec; 11(12):1870-84.
-
Personalized prostate cancer screening: improving PSA tests with genomic information. Sci Transl Med. 2010 Dec 15; 2(62):62ps55.
-
Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet. 2010 Nov 11; 6(11):e1001204.
-
A covering method for detecting genetic associations between rare variants and common phenotypes. PLoS Comput Biol. 2010 Oct 14; 6(10):e1000954.
-
A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations. Cancer Epidemiol Biomarkers Prev. 2010 Oct; 19(10):2639-46.
-
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate. 2009 Aug 01; 69(11):1195-205.
-
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet. 2009 Apr 01; 18(7):1368-75.